The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2022
Filed:
Jun. 27, 2017
Applicant:
Aicuris Anti-infective Cures Gmbh, Wuppertal, DE;
Inventors:
Christian Sinzger, Reutlingen, DE;
Cora Stegmann, Ulm, DE;
Kerstin Laib Sampaio, Dettingen, DE;
Barbara Adler, Munich, DE;
Assignee:
AiCuris Anti-Infective Cures GmbH, Wuppertal, DE;
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/71 (2006.01); A61K 38/17 (2006.01); A61P 31/22 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01); C12N 15/113 (2010.01); C07K 19/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/71 (2013.01); A61K 38/179 (2013.01); A61K 39/0005 (2013.01); A61P 31/22 (2018.01); C07K 16/2863 (2013.01); C12N 15/1138 (2013.01); C07K 19/00 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); C07K 2319/74 (2013.01); C12N 2310/14 (2013.01);
Abstract
Subject matter of the present invention is a soluble PDGFR-alpha-Fc chimera or a PDGFR-alpha derived peptide or an anti-PDGFR-alpha antibody or a PDGFR-alpha antibody fragment or anti-PDGFR-alpha non-Ig scaffold for inhibiting HCMV entry for use in a method of treatment in a subject that has been infected by HCMV or for use in a method of prophylaxis of HCMV infection in a subject that has not yet been infected by HCMV.